The sciatica treatment market size has grown strongly in recent years. It will grow from $4.2 billion in 2023 to $4.57 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed during the historic period can be attributed to several factors, including an increased demand for non-surgical sciatica treatments, a growing emphasis on personalized medicine, expanded healthcare access, heightened awareness and demand for treatment options, and a rising incidence of lower back pain.
The sciatica treatment market size is expected to see strong growth in the next few years. It will grow to $6.49 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The anticipated growth during the forecast period can be attributed to several factors, including the rising prevalence of overweight and obesity, an increase in long-term pain conditions, a growing incidence of chronic diseases, a higher prevalence of sciatica, and enhanced awareness and diagnosis of these issues. Key trends expected in this period include advancements in medical technology, innovations aimed at improving treatment efficacy, developments in medications for sciatic nerve pain, the integration of digital health technologies, and advancements in regenerative medicine.
Rising obesity rates are expected to drive the growth of the sciatica treatment market in the coming years. Obesity is a medical condition characterized by excessive body fat accumulation, leading to health risks such as heart disease, diabetes, and hypertension. The increase in obesity is largely attributed to the easy availability of high-calorie processed foods and increasingly sedentary lifestyles driven by technology and urbanization. Sciatica treatment can assist individuals with obesity by alleviating nerve pain and enhancing mobility through physical therapy and weight management, while also reducing the strain excess body weight places on the spine. For instance, in May 2023, data from Government UK revealed that between 2021 and 2022, an estimated 63.8% of adults in England aged 18 and over were classified as overweight or obese, up from 63.3% in 2020-2021. As a result, the rising obesity rates are boosting the demand for sciatica treatment.
Leading companies in the sciatica treatment market are focusing on developing innovative products, such as advanced foam rollers, to improve pain relief and enhance patient mobility. Advanced foam rollers designed for sciatica pain relief are specialized tools for self-myofascial release, which target tight muscles and improve blood circulation in the lower back, hips, and legs. For example, in July 2024, Rolex Recovery, a US-based provider of recovery tools, introduced a new foam roller specifically designed to relieve sciatica pain. This product features a unique design that targets the sciatic nerve and surrounding muscles, promoting self-myofascial release to reduce inflammation and improve blood flow. Its ergonomic design makes it easy to use in daily routines, whether at home, the gym, or on the go.
In September 2024, Semnur Pharmaceuticals, a US-based late-stage clinical specialty pharmaceutical company, merged with Denali Capital Acquisition Corp. in a deal valued at $2.5 billion. The merger aims to establish a publicly traded biopharmaceutical company to expedite investment in the development and commercialization of Semnur's non-opioid pain management product, SP-102 (SEMDEXA), for sciatica treatment. Denali Capital Acquisition Corp. is a US-based special purpose acquisition company (SPAC).
Major companies operating in the sciatica treatment market are HCA Healthcare, Merck and Co Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Stryker Corporation, Mayo Clinic, Boston Scientific, Johns Hopkins Medicine, DJO Global Inc., Rothman Orthopaedic Institute, Axogen Inc., SCILEX Pharmaceuticals Inc, Medscape, Practo Technologies Private Limited, Aurobindo Pharma, Sinfonia Biotherapeutics, QI Spine Clinic, iCareBetter Inc, OrthoVirginia inc, ReLiva Physiotherapy and Rehab, SpineThera Inc.
North America was the largest region in the sciatica treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sciatica treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sciatica treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Sciatica treatment encompasses various methods aimed at alleviating symptoms associated with sciatica, which is characterized by pain radiating along the sciatic nerve from the lower back through the legs. Treatment plans are typically tailored to the individual, taking into account the underlying cause of sciatica, the severity of symptoms, and the patient’s overall health.
The primary types of sciatica treatment include acute sciatica, chronic sciatica, and others. Acute sciatica involves sudden and intense pain along the sciatic nerve, which extends from the lower back through the hips and buttocks down to each leg. Treatment options for acute sciatica may include prescription medications, steroids, non-steroidal anti-inflammatory drugs (NSAIDs), antidepressants, physical therapy, spinal injections, surgery, alternative therapies, and more. These treatments are accessible through various distribution channels, including hospitals and associated pharmacies, retail pharmacies, and online pharmacies.
The sciatica treatment market research report is one of a series of new reports that provides sciatica treatment market statistics, including sciatica treatment industry global market size, regional shares, competitors with a sciatica treatment market share, detailed sciatica treatment market segments, market trends and opportunities, and any further data you may need to thrive in the sciatica treatment industry. This sciatica treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sciatica treatment market includes revenues earned by entities by providing services such as physical therapy, steroid injections, acupuncture and massage therapy, medications, and surgical intervention. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Sciatica Treatment Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on sciatica treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sciatica treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sciatica treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Acute Sciatica; Chronic Sciatica; Other Types2) By Treatment Type: Prescription Drugs; Steroids; Non-Steroidal Anti-Inflammatory Drugs; Antidepressants; Physical Therapy; Spinal Injections; Surgery; Alternative Therapies; Other Treatment Types
3) By Distribution Channel: Hospitals And Associated Pharmacies; Retail Pharmacies; Online Pharmacies
Key Companies Mentioned: HCA Healthcare; Merck and Co Inc.; Bayer AG; Abbott Laboratories; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies profiled in this Sciatica Treatment market report include:- HCA Healthcare
- Merck and Co Inc.
- Bayer AG
- Abbott Laboratories
- Novartis AG
- Medtronic plc
- Stryker Corporation
- Mayo Clinic
- Boston Scientific
- Johns Hopkins Medicine
- DJO Global Inc.
- Rothman Orthopaedic Institute
- Axogen Inc.
- SCILEX Pharmaceuticals Inc
- Medscape
- Practo Technologies Private Limited
- Aurobindo Pharma
- Sinfonia Biotherapeutics
- QI Spine Clinic
- iCareBetter Inc
- OrthoVirginia inc
- ReLiva Physiotherapy and Rehab
- SpineThera Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | December 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 4.57 Billion |
Forecasted Market Value ( USD | $ 6.49 Billion |
Compound Annual Growth Rate | 9.2% |
Regions Covered | Global |
No. of Companies Mentioned | 24 |